{
    "title": "Diabetes, immune system and Vitamin D \u2013 book chapter \u2013 2019",
    "slug": "diabetes-immune-system-and-vitamin-d-book-chapter-2019",
    "aliases": [
        "/Diabetes+immune+system+and+Vitamin+D+\u2013+book+chapter+\u2013+2019",
        "/11475"
    ],
    "tiki_page_id": 11475,
    "date": "2019-12-18",
    "categories": [
        "Diabetes",
        "Immunity"
    ],
    "tags": [
        "Diabetes",
        "Immunity",
        "autoimmune",
        "diabetes",
        "diabetes and vitamin d receptor",
        "genetics",
        "high dose",
        "intervention",
        "metabolic",
        "metabolic conditions",
        "metabolic syndrome",
        "multiple sclerosis",
        "therapeutic intervention",
        "type 1 diabetes",
        "vitamin d",
        "vitamin d blood test",
        "vitamin d receptor"
    ]
}


#### References

* Akiyama, T., Shinzawa, M., Akiyama, N., 2012. RANKL—RANK interaction in immune regulatory systems. WorldJ. Orthop. 3, 142—150.

* Alfonso, B., Liao, E., Busta, A., Poretsky, L., 2009. Vitamin D in diabetes mellitus—a new field of knowledge poised for D-velopment. Diabetes Metabol. Res. Rev. 25, 417—419.

* Ali, T., El Esawy, B., Elaskary, A.,  **2018** . Effect of paricalcitol on pancreatic oxidative stress, inflammatory markers, and glycemic status in diabetic rats. Ir. J. Med. Sci. 187, 75—84.

* Barragan, M., Good, M., Kolls, J., 2015. Regulation of dendritic cell function by vitamin D. Nutrients 7, 8127—8151.

* Barrat, F., Cua, D., Boonstra, A., Richards, D., Crain, C., Savelkoul, H., et al., 2002. In vitro generation of interleukin 10-producing regulatory CD4 1 T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J.Exp. Med. 195, 603—616.

* Bhalla, A.K., Paavonen, T., Williams, M., Delves, P., Lydyard, P., 1991. Regulation of interleukin-1 and tumour necrosis factor gene expression in myelomonocytic cell lines by 1,25-dihydroxyvitamin D3. Immunology 72, 61 — 64.

* Bikle, D., 2014. Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol. 21, 319—329.

* Bikle, D., 2016. Extraskeletal actions of vitamin D. Ann. N. Y. Acad. Sci. 1376, 29—52.

* Bivona, G., Agnello, L., Ciaccio, M.,  **2017** . Vitamin D and immunomodulation: is it time to change the reference values? Ann. Clin. Lab. Sci. 47, 508—510.

* Bourlon, P., Billaudel, B., Faure-Dussert, A., 1999. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J. Endocrinol. 160, 87—95.

* Brosbol-Ravnborg, A., Bundgaard, B., Hollsberg, P., 2013. Synergy between vitamin D3 and Toll-like receptor agonists regulates human dendritic cell response during maturation. Clin. Dev. Immunol. 2013, 807971.

* Chambers, E., Suwannasaen, D., Mann, E., Urry, Z., Richards, D., Lertmemongkolchai, G., et al., 2014. 1 a,25-Dihydroxyvitamin D3 in combination with transforming growth factor- increases the frequency of Foxp3 1 regulatory T cells through preferential expansion and usage of interleukin-2. Immunology 143, 52—60.

* Chen, J., Bruce, D., Cantorna, M., 2014. Vitamin D receptor expression controls proliferation of naive CD81 T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol. 15, 6.

* Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., Carmeliet, G., 2016. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol. Rev. 96, 365—408.

* Corripio-Miyar, Y., Mellanby, R., Morrison, K., McNeilly, T.,	 **2017** .	1,25-Dihydroxyvitamin D3 modulates the phenotype and function of monocyte derived dendritic cells in cattle. BMC Vet. Res. 13, 390.

* Di Rosa, M., Malaguarnera, G., De Gregorio, C., Palumbo, M., Nunnari, G., Malaguarnera, L., 2012. Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell. Immunol. 280, 36—43.

* Fleet, J.,  **2017** . The role of vitamin D in the endocrinology controlling calcium homeostasis. Mol. Cell. Endocrinol. 453, 36—45.

* Giarratana, N., Penna, G., Amuchastegui, S., Mariani, R., Daniel, K., Adorini, L., 2004. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J. Immunol. 173, 2280—2287.

* Grammatiki, M., Rapti, E., Karras, S., Ajjan, R., Kotsa, K.,  **2017** . Vitamin D and diabetes mellitus: causal or casual association? Rev. Endocr. Metab. Disord. 18, 227—241.

* Gregoriou, E., Mamais, I., Tzanetakou, I., Lavranos, G., Chrysostomou, S.,  **2017** . The effects of vitamin D supplementation in newly diagnosed type 1 dabetes patients: systematic review of randomized controlled trials. Rev. Diabet. Stud. 14, 260—268.

* Gysemans, C., Cardozo, A., Callewaert, H., Giulietti, A., Hulshagen, L., Bouillon, R., et al., 2005. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 146, 1956—1964.

* Han, F., Lv, Y., Gong, L., Liu, H., Wan, Z., Liu, L.,  **2017** . VDR Gene variation and insulin resistance related diseases. Lipids Health Dis. 16, 157.

* Hoseinzadeh, E., Taha, P., Wei, C., Godini, H., Ashraf, G.M., Taghavi, M., et al.,  **2018** . The impact of air pollutants, UV exposure and geographic location on vitamin D deficiency. Food Chem. Toxicol. 113, 241—254.

* Hypponen, E., Laara, E., Reunanen, A., Jarvelin, M., Virtanen, S., 2001. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358, 1500—1503.

* Jeffery, L., Burke, F., Mura, M., Zheng, Y., Qureshi, O., Hewison, M., et al., 2009. 1,25- Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 183, 5458—5467.

* Kagi, L., Bettoni, C., Pastor-Arroyo, E., Schnitzbauer, U., Hernando, N., Wagner, C.,  **2018** . Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. PLoS One 13, e0195427.

* Karonova, T., Grineva, E., Belyaeva, O., Bystrova, A., Jude, E., Andreeva, A., et al.,  **2018** . Relationship between vitamin D status and vitamin D receptor gene polymorphisms with markers of metabolic syndrome among adults. Front. Endocrinol. (Lausanne) 9, 448.

* Kjalarsdottir, L., Tersey, S., Vishwanath, M., Chuang, J., Posner, B., Mirmira, R., et al.,  **2018** . 1,25-Dihydroxyvitamin D3 enhances glucose-stimulated insulin secretion in mouse and human islets: a role for transcriptional regulation of voltage-gated calcium channels by the vitamin D receptor. J. Steroid Biochem. Mol. Biol. 185, 17—26 (ahead of print).

* Labudzynskyi, D., Manoylov, K., Shymansky, I., Veliky, M., 2016a. Immunoregulatory effects of vitamin D3 in experimentally induced type 1 diabetes. Cytol. Genet. 50, 231—240.

* Labudzynskyi, D., Shymanskyy, I., Veliky, M., 2016b. Role of vitamin D3 in regulation of interleukin-6 and osteopontin expression in liver of diabetic mice. Eur. Rev. Med. Pharmacol. Sci. 20, 2916—2919.

* Liu, C., Feng, X., Li, Q., Wang, Y., Li, Q., Hua, M., 2016. Adiponectin, TNF-a and inflammatory cytokines and risk of type 2 diabetes: a systematic review and metaanalysis. Cytokine 86, 100—109.

* Lu, M., Taylor, B., Korner, H.,  **2018** . Genomic effects of the vitamin D receptor: potentially the link between vitamin D, immune cells, and multiple sclerosis. Front. Immunol. 9, 477.

* Mahon, B., Wittke, A., Weaver, V., Cantorna, M., 2003. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell. Biochem. 89, 922—932.

* Mao, L., Ji, F., Liu, Y., Zhang, W., Ma, X., 2014. Calcitriol plays a protective role in diabetic nephropathy through anti-inflammatory effects. Int. J. Clin. Exp. Med. 7, 5437—5444.

* Mazanova, A., Shymanskyi, I., Lisakovska, O., Hajiyeva, L., Komisarenko, Y., Veliky, M.,  **2018** . Effects of cholecalciferol on key components of vitamin D-endo/para/autocrine system in experimental type 1 diabetes. Int. J. Endocrinol.  **2018** , 2494016.

* Moran-Auth, Y., Penna-Martinez, M., Badenhoop, K., 2015. VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients. J. Steroid Biochem. Mol. Biol. 148, 184—186.

* Mousa, A., Naderpoor, N., Teede, H., Scragg, R., de Courten, B.,  **2018** . Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 76, 380—394.

* Neelankal John, A., Iqbal, Z., Colley, S., Morahan, G., Makishima, M., Jiang, F.,  **2018** . Vitamin D receptor-targeted treatment to prevent pathological dedifferentiation of pancreatic 3 cells under hyperglycaemic stress. Diabetes Metab. 44, 269—280.

* Overbergh, L., Stoffels, K., Waer, M., Verstuyf, A., Bouillon, R., Mathieu, C., 2006. Immune regulation of 25-hydroxyvitamin D-1alpha-hydroxylase in human monocytic THP1 cells:	mechanisms of interferon-gamma-mediated induction. J. Clin.Endocrinol. Metab. 91, 3566-3374.

* Penna, G., Adorini, L., 2000. 1-alpha-25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164, 2405—2411.

* Penna-Martinez, M., Badenhoop, K.,  **2017** . Inherited variation in vitamin D genes and type 1 diabetes predisposition, Genes (Basel), 8. p. E125.

* Pramyothin, P., Holick, M., 2012. Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr. Opin. Gastroenterol. 28, 139—150.

* Sato, E., Imafuku, S., Ishii, K., Itoh, R., Chou, B., Soejima, T., et al., 2013. Vitamin D-dependent cathelicidin inhibits mycobacterium marinum infection in human monocytic cells. J. Dermatol. Sci. 70, 166—172.

* Sharp, S., Weedon, M., Hagopian, W., Oram, R.,  **2018** . Clinical and research uses of genetic risk scores in type 1 diabetes. Curr. Opin. Genet. Dev. 50, 96—102.

* Shih, E., Mittelman, S., Pitukcheewanont, P., Azen, C., Monzavi, R., 2016. Effects of vitamin D repletion on glycemic control and inflammatory cytokines in adolescents with type 1 diabetes. Pediatr. Diabetes 17, 36—43.

* Skrobot, A., Demkow, U., Wachowska, M.,  **2018** . Immunomodulatory role of vitamin D: a review. Adv. Exp. Med. Biol. 1108, 13—23.

* Sun, D., Luo, F., Xing, J., Zhang, F., Xu, J., Zhang, Z.,  **2018** . 1,25(OH)2D3 inhibited Th17 cells differentiation via regulating the NF-kB activity and expression of IL-17. Cell Prolif. 51, e12461.

* Szymczak, I., Pawliczak, R., 2016. The active metabolite of vitamin D3 as a potential immunomodulator. Scand. J. Immunol. 83, 83—91.

* Takiishi, T., Ding, L., Baeke, F., Spagnuolo, I., Sebastiani, G., Laureys, J., et al., 2014. Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term. Diabetes 63, 2026—2036.

* Treiber, G., Prietl, B., Frohlich-Reiterer, E., Lechner, E., Ribitsch, A., Fritsch, M., et al., 2015. Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus—a randomized clinical trial. Clin. Immunol. 161, 217—224.

* Wagner, H., Alvarsson, M., Mannheimer, B., Degerblad, M., Ostenson, C., 2016. No effect of high-dose vitamin D treatment on |3-cell function, insulin sensitivity, or glucose homeostasis in subjects with abnormal glucose tolerance: a randomized clinical trial. Diabetes Care 39, 345—352.

* Wolden-Kirk, H., Overbergh, L., Gysemans, C., Brusgaard, K., Naamane, N., Van Lommel, L., et al., 2013. Unraveling the effects of 1,25OH2D3 on global gene expression in pancreatic islets. J. Steroid Biochem. Mol. Biol. 136, 68—79.

* Xie, Z., Munson, S., Huang, N., Portale, A., Miller, W., Bikle, D., 2002. The mechanism of 1,25-dihydroxyvitamin D3 autoregulation in keratinocytes. J. Biol. Chem. 277, 36987—36990.

* Ysmail-Dahlouk, L., Nouari, W., Aribi, M., 2016. 1,25-Dihydroxyvitamin D3 down-modulates the production of proinflammatory cytokines and nitric oxide and enhances the phosphorylation of monocyte-expressed STAT6 at the recent-onset type 1 diabetes. Immunol. Lett. 179, 122—130.